Related Experiment Video
Updated: Mar 2, 2026

08:56
Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies
Published on: October 7, 2021
3.4K
Brachial plexus magnetic resonance imaging differentiates between inflammatory neuropathies and does not predict
Bas A Jongbloed1, Jeroen W Bos1, Dirk Rutgers2
1Department of Neurology University Medical Center Utrecht Utrecht Netherlands.
Brain and Behavior
|May 20, 2017
Summary
Brachial plexus MRI abnormalities correlate with neurological deficits in inflammatory neuropathies. However, MRI findings do not predict disease course or treatment response in multifocal motor neuropathy, Lewis-Sumner syndrome, or CIDP.
Area of Science:
- Neurology
- Radiology
- Immunology
Background:
- Inflammatory neuropathies like multifocal motor neuropathy (MMN), Lewis-Sumner syndrome (LSS), and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) affect the peripheral nervous system.
- Brachial plexus involvement is a key feature in some of these conditions.
- Understanding the relationship between imaging findings and clinical presentation is crucial for diagnosis and management.
Purpose of the Study:
- To assess the correlation between brachial plexus MRI abnormalities and clinical weakness.
- To determine the predictive value of brachial plexus MRI for disease course and treatment response in MMN, LSS, and CIDP.
Main Methods:
- Sixty-seven patients with inflammatory neuropathy underwent bilateral T2 STIR brachial plexus MRI.
- Clinical follow-up data were collected.
- MRIs were scored for abnormalities and symmetry of distribution.
Main Results:
- Brachial plexus MRI abnormalities were found in 45% of patients.
- Asymmetrical abnormalities correlated with asymmetrical syndromes in MMN and LSS (p < .001).
- Symmetrical abnormalities were predominant in CIDP (p < .001).
- Abnormal MRI did not predict disease course, weakness patterns, sensory disturbances, or treatment response.
Conclusions:
- T2 STIR brachial plexus MRI abnormalities align with the distribution of neurological deficits in inflammatory neuropathies.
- Brachial plexus MRI findings do not correlate with specific clinical characteristics, treatment response, or disease progression in MMN, LSS, and CIDP.
Related Concept Videos
Magnetic Resonance Imaging
10.1K
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
10.1K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
532
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
532
Spinal Nerves: Plexus I
3.2K
Nerve plexuses are networks of interlacing nerves that serve as communication hubs to distribute and organize nerve action across various body regions. The nerve plexuses are organized into the cervical plexus located in the neck region, brachial plexus in the shoulder area, lumbar plexus found in the lower back, sacral plexus situated in the pelvis, and coccygeal plexus located in the coccygeal region.
The Cervical Plexus
The cervical plexus, formed by the anterior rami of the first four...
The Cervical Plexus
The cervical plexus, formed by the anterior rami of the first four...
3.2K
Myasthenia Gravis: Diagnostic Tests
2.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
2.9K

